ET WEB_SERVER Oracle E-Business Suite (EBS) CRLF Injection (CVE-2025-61884)

SID: 2065106Rev: 135 views
History
Sourceet/open
CreatedOctober 8, 2025
UpdatedOctober 8, 2025
Classificationweb-application-attack
alert http any any -> $HOME_NET any (msg:"ET WEB_SERVER Oracle E-Business Suite (EBS) CRLF Injection (CVE-2025-61884)"; flow:established,to_server; xbits:set,ET.OracleEBS.CVE_2025_61882,track ip_dst; http.uri; content:"/OA_HTML/configurator/UiServlet"; fast_pattern; http.request_body; content:"redirectFromJsp|3d|1"; content:"getUiType|3d|"; content:"return_url"; pcre:"/^(?:(?!\x3c\x2f|\x25(?:25)?3[cC]\x25(?:25)?2[fF]).)+(?:(?:(?:\x26|\x25(?:25)?26)(?:\x23|\x25(?:25)?23)(?:13|x0[dD])(?:\x3b|\x25(?:25)?3[bB])|\x0d|\x25(?:25)?0[dD])(?:(?:\x26|\x25(?:25)?26)(?:(?:\x23|\x25(?:25)?23)(?:x0[aA]|10)|NewLine)(?:\x3b|\x25(?:25)?3[bB])|\x0a|\x25(?:25)?0[aA]))(?:HEAD|GET|POST|PUT|OPTIONS|TRACE|DELETE)/R"; reference:url,labs.watchtowr.com/well-well-well-its-another-day-oracle-e-business-suite-pre-auth-rce-chain-cve-2025-61882well-well-well-its-another-day-oracle-e-business-suite-pre-auth-rce-chain-cve-2025-61882/; reference:cve,2025-61884; classtype:web-application-attack; sid:2065106; rev:1; metadata:affected_product Oracle_EBS, attack_target Server, tls_state TLSDecrypt, created_at 2025_10_08, cve CVE_2025_61884, deployment Perimeter, deployment Internal, confidence High, signature_severity Major, tag Exploit, tag Description_Generated_By_Proofpoint_Nexus, updated_at 2025_10_08, mitre_tactic_id TA0001, mitre_tactic_name Initial_Access, mitre_technique_id T1190, mitre_technique_name Exploit_Public_Facing_Application; target:dest_ip;)

Metadata

affected productOracle_EBS
attack targetServer
tls stateTLSDecrypt
created at2025_10_08
deploymentInternal
confidenceHigh
signature severityMajor
tagDescription_Generated_By_Proofpoint_Nexus
updated at2025_10_08
mitre tactic idTA0001
mitre tactic nameInitial_Access
mitre technique idT1190
mitre technique nameExploit_Public_Facing_Application

Comments (0)

Please sign in to leave a comment.
Sign in

No comments yet. Be the first to comment!